Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.95 -0.02 (-1.69%)
As of: Sep 29, 2026 · 3:59 PM EDT

Lineage Cell Therapeutics (LCTX) Operating Expenses (2010 - 2026)

Updated

Lineage Cell Therapeutics' Operating Expenses was $9.99 million in Q2 2026, down 55.7% from $22.55 million a year earlier but up 7.2% from the prior quarter.

Analysis

Lineage Cell Therapeutics (LCTX) Operating Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Lineage Cell Therapeutics' Operating Expenses was $39.93 million through Jun 30, 2026, down 13.5% year-over-year; for FY2025, it was $51.18 million, up 65.2% from FY2024.

  • Operating Expenses shows a five-year compound annual growth rate of 12.9% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $30.98 million in FY2024 (-8.0%), $33.68 million in FY2023 (-7.7%), $36.5 million in FY2022 (-30.0%) and $52.13 million in FY2021 (+86.9%).
  • Quarterly Operating Expenses has moved between $7.28 million (Q2 2024) and $29.2 million (Q4 2021) over five years.
  • Compared with a year earlier, Operating Expenses was higher in three of the last eight quarters, with growth averaging 28.2%.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2021 (growth of 376.9%); the worst was Q4 2022 (a decline of 71.1%).
  • Per Business Quant data, LCTX's Operating Expenses in the three quarters before Q2 2026 was $9.32 million (Q1 2026), $13.16 million (Q4 2025) and $7.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Lineage Cell Therapeutics 245.32 Mn 43.73 Mn - 9.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.99 Mn
Mar 31, 2026 9.32 Mn
Dec 31, 2025 13.16 Mn
Sep 30, 2025 7.47 Mn
Jun 30, 2025 22.55 Mn
Mar 31, 2025 8.01 Mn
Dec 31, 2024 7.98 Mn
Sep 30, 2024 7.62 Mn
Jun 30, 2024 7.28 Mn
Mar 31, 2024 8.11 Mn
Dec 31, 2023 8.19 Mn
Sep 30, 2023 7.95 Mn
Jun 30, 2023 8.25 Mn
Mar 31, 2023 9.03 Mn
Dec 31, 2022 8.45 Mn
Sep 30, 2022 8.01 Mn
Jun 30, 2022 8.57 Mn
Mar 31, 2022 11.46 Mn
Dec 31, 2021 29.20 Mn
Sep 30, 2021 8.13 Mn
API Access

Lineage Cell Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=LCTX&period=max&api_key=YOUR_API_KEY